Statement of Changes in Beneficial Ownership (4)
September 09 2020 - 8:48AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Lefkowitz Steven W |
2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc.
[
CRMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O CORMEDIX INC., 400 CONNELL DRIVE, SUITE 5000 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/4/2020 |
(Street)
BERKELEY HEIGHTS, NJ 07922
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 9/4/2020 | | P | | 3500.0000 | A | $4.0000 | 58283.0000 | D | |
Common Stock | 9/4/2020 | | P | | 2215.0000 | A | $3.9800 | 60498.0000 | D | |
Common Stock | | | | | | | | 30152.0000 | I (1) | Wade Capital Corp Money Purchase Plan |
Common Stock | | | | | | | | 2000.0000 | I | Reporting Person's Wife |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy Common Stock) | $5.6300 | | | | | | | (2) | 2/25/2030 | Common Stock | 15000.0000 | | 15000.0000 | D | |
Stock Option (Right to Buy Common Stock) | $8.3000 | | | | | | | (3) | 1/10/2029 | Common Stock | 15000.0000 | | 15000.0000 | D | |
Stock Option (Right to Buy Common Stock) | $2.8500 | | | | | | | (4) | 2/16/2028 | Common Stock | 8000.0000 | | 8000.0000 | D | |
Stock Option (Right to Buy Common Stock) | $2.2500 | | | | | | | (5) | 6/25/2027 | Common Stock | 15000.0000 | | 15000.0000 | D | |
Explanation of Responses: |
(1) | The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control). |
(2) | These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. |
(3) | These options were granted on 01/10/2019. The options are fully vested. |
(4) | These options were granted on 2/16/2018. These options are fully vested. |
(5) | These options were granted on 6/25/2017. These options are fully vested. |
Remarks: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Lefkowitz Steven W C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS, NJ 07922 | X |
|
|
|
Signatures
|
/s/ Steven W. Lefkowitz | | 9/9/2020 |
**Signature of Reporting Person | Date |
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024